β-Amyloid (35-25)
CAS No. 147740-73-6
β-Amyloid (35-25)( ——— )
Catalog No. M40704 CAS No. 147740-73-6
β-Amyloid (35-25) is areverse version of β-Amyloid (25-35) .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Nameβ-Amyloid (35-25)
-
NoteResearch use only, not for human use.
-
Brief Descriptionβ-Amyloid (35-25) is areverse version of β-Amyloid (25-35) .
-
Descriptionβ-Amyloid (35-25) is areverse version of β-Amyloid (25-35) .
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number147740-73-6
-
Formula Weight1060.29
-
Molecular FormulaC45H81N13O14S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
TM-N1324
TM-N1324 is a GPR39 agonist. TM-N1324 activates human GPR39 with high efficacy and potencies of 280 nM and 9 nM in the absence and presence of Zn2+, respectively.
-
NAI
NAI is an RNA SHAPE reagent.
-
Isogambogenic acid
Isogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy.
Cart
sales@molnova.com